Investors, Insurers Embrace Outpatient Addiction Care, But Residential Care Is Far From Extinct

In recent years, substance use disorder (SUD) treatment programs have become shorter and outpatient treatment program options have become more popular. Residential inpatient treatment programs, often more expensive than outpatient options, may be going out of vogue among payers and investors. Still, patients will always need an option for residential care, industry insiders told Addiction […]

Clinicians Lack Sufficient Awareness of Novel Synthetic Opioid 10 Times More Potent Than Fentanyl

A class of synthetic opioids that are 10 times as potent as fentanyl is becoming increasingly prevalent in the United States. The substance use disorder (SUD) industry may not be sufficiently prepared for its impacts. Nitazenes, a class of synthetic opioids first developed in the 1950s as opioid analgesics and never approved to market, are […]

Behavioral Health Provider Turnbridge Pursues Sale, Promotes $15M EBITDA 

Behavioral health operator Turnbridge is in talks to sell, touting about $15 million of EBITDA. Turnbridge, which provides mental health and substance use disorder (SUD) care, is pursuing a sale of the company, according to Axios. Investment banking firm Raymond James was hired to lead the sale, sources say.  New Haven, Connecticut-based Turnbridge offers gender-specific […]

Addiction Providers Embrace Harm Reduction and MAT, But Abstinence-Based Treatment Isn’t Dead Yet

The substance use disorder (SUD) treatment industry is beginning to move away from an abstinence-only approach to care toward harm-reduction and medication-assisted treatment approaches. Research demonstrates that abstinence-based SUD treatment is deadlier than no treatment at all. Despite shifts in the industry away from a concept of recovery that involves strict abstinence, providers say that […]

Bipartisan Support Means Substance Use Disorder Providers Are Immune to Election-Year Turmoil

Election years can be a tumultuous time for behavioral health providers, with policy priorities set to change with the potential transition of power. The substance use disorder (SUD) treatment industry can not only expect to be exempt from this turmoil but also enjoy more robust support from federal and state governments this year. Election cycles […]

Only 1 in 3 Opioid Use Disorder Facilities Offer Buprenorphine Injections

Medications for opioid use disorder (MOUDs), including buprenorphine, save lives among people with opioid use disorder (OUD). Long-lasting injectable versions offer the same benefits and can help patients adhere to medication schedules.  Despite injectable buprenorphine’s benefits, a new study published in JAMA found that the class of drugs is only available at one-third of substance […]

SUD Industry Has Evolved But Still Has a ‘Lot of White Space’ for Consolidation 

The outpatient substance use disorder (SUD) industry has evolved from a landscape of mom-and-pop businesses to a field dominated by sophisticated providers seeking to provide quality care. While the SUD industry has matured over the last decade, it still faces significant roadblocks like stigma surrounding medication-assisted treatment (MAT) and fragmentation. The splintered SUD market offers […]

CMS Launches ‘Revolutionary’ New Behavioral Health, Primary Care Integration Model

The Centers for Medicare & Medicaid Services (CMS) is working to improve access to behavioral health with a new initiative designed to integrate behavioral health with physical health. The newly launched program, called the Innovation in Behavioral Health (IBH) Model, will connect adults with mental health conditions or substance use disorders (SUDs) to physical, behavioral […]

Novel Opioid Poppy Seed Tea Requires Similar Doses of Buprenorphine to Heroin

Clinicians may not be fully aware of poppy seed tea, a novel opioid made using easily obtained unwashed poppy seeds. Poppy seed tea has similar risks to other opioids, including the potential for death, according to research led by Scott Weiner, Bicycle Health’s director of research and emergency physician. Patients who seek treatment for poppy […]

SUD Provider Eleanor Names Sevita Vet William McKinney CEO

Substance use disorder provider Eleanor has named Sevita vet William McKinney its new CEO.  In McKinney’s previous role as CEO of home and community IDD provider Sevita, he led a team of 45,000 employees that served 55,000 individuals. His resume also includes tenure as president of Integrated Care Group for Fresenius Medical Care and vice […]